Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy.

Patients who received NHT had a higher risk of a rapid PSA increase when they experienced BCR, especially within 2 years after RP. In order to not miss the optimal timing of salvage treatment for BCR, intensive PSA follow-up is necessary.